Basic Search  |  Summaries  |  Advanced Search

Violation Tracker Individual Record

Company: Lunada Biomedical, Inc.
Penalty: $250,000
Year: 2016
Date: May 20, 2016
Offense Group: consumer-protection-related offenses
Primary Offense: consumer protection violation
Violation Description: Lunada Biomedical, Inc. and its three principals settled Federal Trade Commission charges that they deceptively marketed Amberen, a dietary supplement, to women over 40 who are perimenopausal or menopausal, making a range of unsupported claims.
Level of Government: federal
Action Type: agency action
Agency: Federal Trade Commission
Civil or Criminal Case: civil
Source of Data: (click here)
Archived Source: (click here)
Current parent company note: Parent-subsidiary relationship is current as of the most recent revision listed in the Update Log.